News

meniscal injuries

Editorial Bioteck

14 June 2023

Hydrolyzed collagen reduces pain in meniscal injuries and post-meniscectomy syndrome

Today we present a case series on the efficacy of CHondroGrid® in meniscopathy and post-meniscectomy syndrome treatment, published in the Italian Journal “Tabloid dell’Ortopedia”.

 

CHondroGrid® consists of 4 mg of lyophilized low-molecular-weight (<3.3 kDa) collagen peptides, which are resuspended in 2 ml of water for injection. Once injected, the peptides quickly diffuse into the tissue going directly to reinforce the extracellular matrix.

 

The case series included 11 patients, of whom 6 treated following meniscectomy and 5 with meniscopathy, who were unresponsive to HA infiltration and underwent treatment with CHondroGrid®.

 

The results show that CHondroGrid® is effective in reducing pain > 90% at 6-month follow-up…

 

> Click here to download the article

 

Logo Bioteck Academy


Vicenza
Headquarter
via E. Fermi, 49
36057 Arcugnano, Vicenza (VI) - Italy
Tel. +39 0444 289366
Fax: +39 0444 285272


Contact us


Torino
Multi-function production center
Via G. Agnelli, 3
10020 Riva presso Chieri, Torino (TO) - Italy

Copyright © 2024 Bioteck S.p.A. - Privacy Policy - Cookie Policy